Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year gross profit growth rate
Latest
283.15%
↑ 133% above average
Average (9y)
121.36%
Historical baseline
Range
High:537.61%
Low:-292.53%
CAGR
-3.5%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 283.15% |
| 2023 | 239.49% |
| 2022 | 91.29% |
| 2021 | -292.53% |
| 2020 | -2.12% |
| 2019 | 23.06% |
| 2018 | 537.61% |
| 2017 | -79.55% |
| 2016 | 22.11% |
| 2015 | 391.07% |